• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.1994年至2004年新英格兰北部尿路上皮膀胱癌分级和分期的分布及时间趋势分析
ISRN Pathol. 2012;2012. doi: 10.5402/2012/283670.
2
Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.低度恶性潜能的乳头状尿路上皮肿瘤:诊断可靠性与预后
BJU Int. 2004 Jun;93(9):1228-31. doi: 10.1111/j.1464-410X.2004.04848.x.
3
Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional Experience Focusing on Tumors With Borderline Features.膀胱非浸润性乳头状尿路上皮癌:关注具有交界性特征肿瘤的机构经验。
Arch Pathol Lab Med. 2024 Feb 1;148(2):223-229. doi: 10.5858/arpa.2022-0268-OA.
4
Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia.角蛋白 17 是尿路上皮肿瘤的一种敏感且特异的生物标志物。
Mod Pathol. 2019 May;32(5):717-724. doi: 10.1038/s41379-018-0177-5. Epub 2018 Nov 15.
5
Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States.美国东北部一项基于人群的研究中,新诊断膀胱癌的组织学分类与分期
Scand J Urol Nephrol. 2008;42(3):237-42. doi: 10.1080/00365590801948166.
6
Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification.非肌肉浸润性乳头状尿路上皮肿瘤的多参数分类:结合形态学、表型和分子特征进行风险分层。
Int J Mol Sci. 2022 Jul 23;23(15):8133. doi: 10.3390/ijms23158133.
7
Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP).低恶性潜能的乳头状尿路上皮肿瘤(PUNLMP)的再评估。
Histopathology. 2020 Oct;77(4):525-535. doi: 10.1111/his.14192. Epub 2020 Sep 13.
8
Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms.乳头状尿路上皮肿瘤在组织学恶性进展和细胞遗传学非整倍体形成之前的短端粒和染色体不稳定性。
Urol Oncol. 2014 Feb;32(2):135-45. doi: 10.1016/j.urolonc.2012.12.005. Epub 2013 Mar 17.
9
[New WHO classification of urothelial carcinoma of the urinary bladder].[世界卫生组织膀胱尿路上皮癌新分类]
Verh Dtsch Ges Pathol. 2002;86:57-66.
10
Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC).初次经尿道膀胱肿瘤电切术后低恶性潜能乳头状尿路上皮肿瘤(PUNLMP):与非侵袭性低级别乳头状尿路上皮癌(LGPUC)的比较分析
J Cancer. 2017 Aug 24;8(15):2885-2891. doi: 10.7150/jca.20003. eCollection 2017.

引用本文的文献

1
Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.经尿道膀胱肿瘤切除术治疗非肌肉浸润性膀胱癌:蓝激光与白光比较。
Cochrane Database Syst Rev. 2021 Dec 1;12(12):CD013776. doi: 10.1002/14651858.CD013776.pub2.
2
Mitochondrial DNA mutations in Malaysian female breast cancer patients.马来西亚女性乳腺癌患者的线粒体 DNA 突变。
PLoS One. 2020 May 22;15(5):e0233461. doi: 10.1371/journal.pone.0233461. eCollection 2020.
3
Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.新英格兰北部膀胱癌发病率升高:饮用水与砷的作用。
J Natl Cancer Inst. 2016 May 2;108(9). doi: 10.1093/jnci/djw099. Print 2016 Sep.

本文引用的文献

1
Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system.非浸润性乳头状尿路上皮肿瘤:2004 年 WHO/国际泌尿病理学会分类系统。
Pathol Int. 2010 Jan;60(1):1-8. doi: 10.1111/j.1440-1827.2009.02477.x.
2
A case-control study of smoking and bladder cancer risk: emergent patterns over time.一项关于吸烟与膀胱癌风险的病例对照研究:随时间推移出现的模式
J Natl Cancer Inst. 2009 Nov 18;101(22):1553-61. doi: 10.1093/jnci/djp361. Epub 2009 Nov 16.
3
Staging and reporting of urothelial carcinoma of the urinary bladder.膀胱尿路上皮癌的分期与报告
Mod Pathol. 2009 Jun;22 Suppl 2:S70-95. doi: 10.1038/modpathol.2009.1.
4
Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.尿路上皮癌的监测:1993 - 2005年分期和分级变化以及1993 - 2000年生存趋势
Cancer. 2009 Apr 1;115(7):1435-47. doi: 10.1002/cncr.24147.
5
Molecular alterations associated with bladder cancer initiation and progression.与膀胱癌起始和进展相关的分子改变。
Scand J Urol Nephrol Suppl. 2008 Sep(218):154-65. doi: 10.1080/03008880802291915.
6
Renal cell cancer stage migration: analysis of the National Cancer Data Base.肾细胞癌分期迁移:美国国立癌症数据库分析
Cancer. 2008 Jul 1;113(1):78-83. doi: 10.1002/cncr.23518.
7
Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States.美国东北部一项基于人群的研究中,新诊断膀胱癌的组织学分类与分期
Scand J Urol Nephrol. 2008;42(3):237-42. doi: 10.1080/00365590801948166.
8
Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease.1981年至2004年佛罗里达州膀胱癌发病趋势:在减少晚期疾病方面进展甚微。
J Urol. 2008 Feb;179(2):491-5; discussion 495. doi: 10.1016/j.juro.2007.09.082.
9
Morphological diagnosis of urothelial neoplasms.尿路上皮肿瘤的形态学诊断
J Clin Pathol. 2008 Jan;61(1):3-10. doi: 10.1136/jcp.2007.049312. Epub 2007 Jun 1.
10
Urothelial tumorigenesis: a tale of divergent pathways.尿路上皮肿瘤发生:不同途径的故事。
Nat Rev Cancer. 2005 Sep;5(9):713-25. doi: 10.1038/nrc1697.

1994年至2004年新英格兰北部尿路上皮膀胱癌分级和分期的分布及时间趋势分析

Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.

作者信息

Schned Alan R, Lenz Petra, Moore Lee E, Johnson Alison, Jones Michael, Kida Masatoshi, Silverman Debra T, Schwenn Molly, Kelsey Karl T, Andrew Angeline S, Baris Dalsu, Karagas Margaret R

机构信息

Department of Pathology, Dartmouth Medical School, Hanover, New Hampshire USA.

Division of Cancer Epidemiology and Genetics, Science Applications International Corporation-Frederick, Inc., National Cancer Institute-Frederick, Frederick, MD 21702.

出版信息

ISRN Pathol. 2012;2012. doi: 10.5402/2012/283670.

DOI:10.5402/2012/283670
PMID:24683496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3966206/
Abstract

We investigate the distribution of bladder tumor category and stage in Northern New England by geographic region, smoking status and over time. 1091 incident bladder cancer cases from the New England Bladder Cancer Study (NEBCS), a large population-based case-control study carried out in Maine, New Hampshire and Vermont (2001-2004), and 680 bladder cancer cases from previous case-control studies in New Hampshire (1994-2000) were used in the analysis. Of 1091 incident bladder cancer cases from the NEBCS, 26.7% of tumors were papillary urothelial neoplasms of low malignant potential (PUNLMP), 26.8% low-grade papillary urothelial carcinomas (PUC-LG), 31.3% high-grade papillary urothelial carcinomas (PUC-HG), 9.1% non-papillary urothelial carcinomas (non-PUC), and 4.3% carcinoma in situ (CIS). Approximately 70% of cases were non-invasive (Tis/Ta), and all PUNLMP cases were of the Ta category. By contrast, half of all PUC-HG carcinomas were invasive. Short-term time trend analysis within the NEBCS (2001-2004) indicated an increase in the percentage of PUNLMP (p-trend<0.0001) paralleled by a decrease in PUC-LG (p-trend=0.02), and for PUC-LG an increase in the percentage of non-invasive tumors (p-trend 0.04). Our findings suggest possible short-term trends with an increase in the percentage of PUNLMP and a change in the percentage of PUC-LG towards non-invasive disease.

摘要

我们按地理区域、吸烟状况以及随时间推移,对新英格兰北部膀胱肿瘤的类别和分期分布情况展开研究。分析采用了新英格兰膀胱癌研究(NEBCS)中的1091例原发性膀胱癌病例,该研究是在缅因州、新罕布什尔州和佛蒙特州开展的一项大型基于人群的病例对照研究(2001 - 2004年),以及新罕布什尔州此前病例对照研究(1994 - 2000年)中的680例膀胱癌病例。在NEBCS的1091例原发性膀胱癌病例中,26.7%的肿瘤为低恶性潜能乳头状尿路上皮肿瘤(PUNLMP),26.8%为低级别乳头状尿路上皮癌(PUC - LG),31.3%为高级别乳头状尿路上皮癌(PUC - HG),9.1%为非乳头状尿路上皮癌(非PUC),4.3%为原位癌(CIS)。约70%的病例为非侵袭性(Tis/Ta),所有PUNLMP病例均为Ta类别。相比之下,所有PUC - HG癌中有一半为侵袭性。NEBCS(2001 - 2004年)内的短期时间趋势分析表明,PUNLMP的百分比有所增加(p趋势<0.0001),同时PUC - LG的百分比有所下降(p趋势 = 0.02),并且对于PUC - LG,非侵袭性肿瘤的百分比有所增加(p趋势 = 0.04)。我们的研究结果表明可能存在短期趋势,即PUNLMP的百分比增加,以及PUC - LG向非侵袭性疾病的百分比变化。